Molecular Partners Ag (MOLN) Total Liabilities (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Total Liabilities for 7 consecutive years, with $21.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Liabilities rose 2.15% year-over-year to $21.7 million in Q2 2026; TTM through Jun 2026 was $21.7 million, a 2.15% increase from a year earlier, with the FY2025 full-year figure at $26.3 million, up 36.77% from the prior year.
• Total Liabilities was $21.7 million for Q2 2026 at Molecular Partners Ag, down from $24.5 million in the prior quarter.
• Over five years, Total Liabilities peaked at $51.3 million in Q1 2022 and troughed at $14.4 million in Q1 2025.
• A 5-year average of $24.9 million and a median of $24.4 million in 2026 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities tumbled 60.34% in 2022 and surged 70.88% in 2026, its largest moves.
• Over 5 years, Total Liabilities stood at $28.1 million in 2022, then retreated by 12.12% to $24.7 million in 2023, then slipped by 21.98% to $19.3 million in 2024, then jumped by 41.28% to $27.2 million in 2025, then dropped by 20.32% to $21.7 million in 2026.
• The last three Total Liabilities figures came in at $21.7 million (Q2 2026), $24.5 million (Q1 2026), and $27.2 million (Q4 2025), per Business Quant data.